Study Type
Interventional - Procedure
A hip fracture causes bleeding, pain and immobility, and initiates inflammatory, hypercoagulable, catabolic and stress states in patients. Accelerated surgery may improve outcomes by reducing the duration of these states and immobility.
The objective of the HIP ATTACK-1 trial is to determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 90-day risk of the following two co-primary outcomes: all-cause mortality and major perioperative complications.
Primary outcome measures:
1) All-cause mortality; and
2) composite of major perioperative complications:
i.e., mortality, nonfatal myocardial infarction, nonfatal venous thromboembolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, nonfatal life-threatening bleeding, and major bleeding) at 90 days after randomization.
Mohit Bhandari is Co-Principal Investigator of the HIP ATTACK-1 trial, along with PJ Devereaux.
HIP ATTACK Slides - Download PDFInterventional - Procedure
Multicentre, parallel group RCT
17
69
2970
2014 - 2020
PHRI
Back To Top